Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Theseus Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 69
- −3 vs. Q1 2023
- Shares held
- 40.0M
- +509.8K (+1.3%) vs. Q1 2023
- Total value
- $373.6M
- +$23.0M (+6.6%) vs. Q1 2023
- New holders
- 10
- 27 more added
- Sold out
- 13
- 13 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 17,233,668 | $160.8M | 3.13% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 3,585,346 | $33.5M | 24.43% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 2,248,194 | $21.0M | 1.25% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 1,950,327 | $18.2M | 1.47% | +445,000+29.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,400,352 | $13.1M | 0.28% | +1,400,352 | New |
| BlackRock Inc. | 1,333,868 | $12.4M | 0.00% | +450,406+51.0% | Added |
| Price T Rowe Associates Inc | 1,256,009 | $11.7M | 0.00% | −69,556−5.2% | Reduced |
| FMR LLC | 805,641 | $7.52M | 0.00% | −308,021−27.7% | Reduced |
| VR Adviser, LLC | 770,000 | $7.18M | 1.15% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 757,009 | $7.06M | 4.63% | −4,249−0.6% | Reduced |
| Vanguard Group Inc | 731,425 | $6.82M | 0.00% | +30,464+4.3% | Added |
| Omega Fund Management, LLC | 711,479 | $6.64M | 3.72% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 633,423 | $5.93M | 0.00% | +172,695+37.5% | Added |
| Nextech Invest AG | 611,310 | $5.70M | 1.94% | 00.0% | Unchanged |
| Citadel Advisors LLC | 604,550 | $5.64M | 0.01% | +120,164+24.8% | Added |
| Opaleye Management Inc. | 597,500 | $5.57M | 1.33% | +109,400+22.4% | Added |
| Rock Springs Capital Management LP | 437,329 | $4.08M | 0.10% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 421,522 | $3.93M | 0.00% | +93,652+28.6% | Added |
| State Street Corp | 367,516 | $3.43M | 0.00% | +70,652+23.8% | Added |
| Boxer Capital, LLC | 350,000 | $3.27M | 0.15% | 00.0% | Unchanged |
| Bank of Montreal | 277,074 | $2.80M | 0.00% | +277,074 | New |
| Candriam Luxembourg S.C.A. | 270,015 | $2.52M | 0.02% | −53,801−16.6% | Reduced |
| Affinity Asset Advisors, LLC | 240,244 | $2.24M | 0.88% | +142,023+144.6% | Added |
| Driehaus Capital Management LLC | 232,693 | $2.17M | 0.03% | +6,492+2.9% | Added |
| Alliancebernstein L.P. | 218,478 | $2.04M | 0.00% | +64,161+41.6% | Added |
| Laurion Capital Management LP | 179,619 | $1.68M | 0.07% | 00.0% | Unchanged |
| Northern Trust Corp | 164,115 | $1.53M | 0.00% | +30,655+23.0% | Added |
| Wellington Management Group LLP | 153,673 | $1.43M | 0.00% | +42,061+37.7% | Added |
| Ensign Peak Advisors, Inc | 142,598 | $1.33M | 0.00% | 00.0% | Unchanged |
| HighVista Strategies LLC | 136,719 | $1.28M | 0.58% | +136,719 | New |
| Millennium Management LLC | 128,995 | $1.20M | 0.00% | +48,960+61.2% | Added |
| UBS Oconnor LLC | 121,452 | $1.13M | 0.02% | +10,737+9.7% | Added |
| TD Asset Management Inc | 106,948 | $997.8K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 87,881 | $819.9K | 0.00% | +8,130+10.2% | Added |
| Nuveen Asset Management, LLC | 82,478 | $769.5K | 0.00% | +60,629+277.5% | Added |
| Dimensional Fund Advisors LP | 78,993 | $737.0K | 0.00% | +78,993 | New |
| Tekla Capital Management LLC | 75,000 | $699.8K | 0.03% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 59,553 | $555.6K | 0.00% | +7,691+14.8% | Added |
| Charles Schwab Investment Management Inc | 56,203 | $524.4K | 0.00% | +11,092+24.6% | Added |
| Two Sigma Investments, LP | 51,801 | $483.3K | 0.00% | −22,288−30.1% | Reduced |
| Renaissance Technologies LLC | 41,200 | $384.0K | 0.00% | −89,400−68.5% | Reduced |
| Morgan Stanley | 39,977 | $373.0K | 0.00% | −1,910−4.6% | Reduced |
| Hudson Bay Capital Management LP | 35,000 | $326.6K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 30,200 | $281.8K | 0.00% | +1,800+6.3% | Added |
| Goldman Sachs Group Inc | 28,941 | $270.0K | 0.00% | +28,941 | New |
| Rhumbline Advisers | 27,297 | $254.7K | 0.00% | +1,475+5.7% | Added |
| Denali Advisors LLC | 16,500 | $153.9K | 0.05% | +16,500 | New |
| JPMorgan Chase & Co | 15,713 | $146.6K | 0.00% | +2,676+20.5% | Added |
| Exchange Traded Concepts, LLC | 14,791 | $138.0K | 0.00% | +14,791 | New |
| Principal Financial Group Inc | 10,679 | $99.6K | 0.00% | +10,679 | New |
| MetLife Investment Management | 10,330 | $96.4K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 9,741 | $90.9K | 0.00% | +1,540+18.8% | Added |
| New York State Common Retirement Fund | 9,534 | $89.0K | 0.00% | −18−0.2% | Reduced |
| Barclays PLC | 8,365 | $78.0K | 0.00% | −4,628−35.6% | Reduced |
| Deutsche Bank AG | 7,974 | $74.4K | 0.00% | −2,670−25.1% | Reduced |
| Wells Fargo & Company | 7,709 | $71.9K | 0.00% | +4,702+156.4% | Added |
| California State Teachers Retirement System | 6,732 | $62.8K | 0.00% | +415+6.6% | Added |
| Citigroup Inc | 6,029 | $56.3K | 0.00% | +6,029 | New |
| UBS Group AG | 4,230 | $39.5K | 0.00% | −2,621−38.3% | Reduced |
| Bank of America Corp | 4,002 | $37.3K | 0.00% | −175,200−97.8% | Reduced |
| Advisor Group Holdings, Inc. | 2,793 | $26.1K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 2,700 | $25.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,112 | $20.0K | 0.00% | +1,083+105.2% | Added |
| Legal & General Group Plc | 1,930 | $18.0K | 0.00% | +497+34.7% | Added |
| Amalgamated Bank | 1,796 | $17.0K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,126 | $10.5K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 889 | $8.29K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 698 | $6.51K | 0.00% | −720−50.8% | Reduced |
| Federated Hermes, Inc. | 163 | $1.52K | 0.00% | +163 | New |
| Fairmount Funds Management LLC | 0 | $0 | 0.00% | −1,865,671−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −179,550−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −143,980−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −131,025−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −112,614−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −78,369−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −18,081−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −17,543−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −15,859−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −1,660−100.0% | Sold out |
| Psagot Value Holdings Ltd. / (Israel) | 0 | $0 | 0.00% | −274−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −16−100.0% | Sold out |